2008
DOI: 10.1016/j.jvir.2007.10.020
|View full text |Cite
|
Sign up to set email alerts
|

Iodized Oil Accumulation in Hypervascular Hepatocellular Carcinoma after Transcatheter Arterial Chemoembolization: Comparison of Imaging Findings with CT during Hepatic Arteriography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
7
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(8 citation statements)
references
References 18 publications
1
7
0
Order By: Relevance
“…In relation to this, a discrepancy was noted between the tumor enhancement on selective CTHA with balloon occlusion and a dense LE accumulation after B-TACE, which was higher than the tumor enhancement grade[ 31 ]. Although CBCT[ 33 - 35 ] and CTHA[ 36 , 37 ] are well known to be useful tools for identifying the tumor-feeding arteries, evaluating the embolized area and avoiding nontargeted embolization, the same findings were reported in selective C-TACE[ 38 ]. A validation study will be needed to confirm whether or not a decreased tumor enhancement after balloon occlusion can predict the short- and long-term therapeutic effects.…”
Section: Mechanism Of B-tacementioning
confidence: 99%
“…In relation to this, a discrepancy was noted between the tumor enhancement on selective CTHA with balloon occlusion and a dense LE accumulation after B-TACE, which was higher than the tumor enhancement grade[ 31 ]. Although CBCT[ 33 - 35 ] and CTHA[ 36 , 37 ] are well known to be useful tools for identifying the tumor-feeding arteries, evaluating the embolized area and avoiding nontargeted embolization, the same findings were reported in selective C-TACE[ 38 ]. A validation study will be needed to confirm whether or not a decreased tumor enhancement after balloon occlusion can predict the short- and long-term therapeutic effects.…”
Section: Mechanism Of B-tacementioning
confidence: 99%
“…High concentrations of the drug-delivery vehicle lipiodol in the tumor at the time of treatment are associated with lower risks of local tumor recurrence [14] . MPT (cis-[((1R, 2R)-1, 2-cyclohexanediamine-N, N0)bis(-myristato)]-platinum(II) monohydrate; Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan) is a novel lipophilic cisplatin derivative that can be suspended in lipiodol [3,15,16] .…”
Section: Discussionmentioning
confidence: 99%
“…For example, if DCR is identified, other blood vessels (hepatic or nonhepatic) can be interrogated to determine if they supply the tumor, or ablation of the underembolized portion of the tumor could be performed. Spasm resulting from guidewire or catheter manipulation in a feeding vessel is another potential cause of a defect in contrast retention and embolization failure [21]. This could be considered at the time of treatment, if DCR is identified, and potentially reversed with vasodilators.…”
Section: Discussionmentioning
confidence: 99%